2xnz
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 2xnz is ON HOLD Authors: Daldrop, P., Reyes, F.E., Robinson, D.A., Hammond, C.M., Lilley, D.M.J., Batey, R.T., Brenk, R. Description: XPT-PBUX C74U...) |
|||
| (9 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==xpt-pbuX C74U Riboswitch from B. subtilis bound to acetoguanamine identified by virtual screening== | |
| + | <StructureSection load='2xnz' size='340' side='right'caption='[[2xnz]], [[Resolution|resolution]] 1.59Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[2xnz]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Bacillus_subtilis Bacillus subtilis]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2XNZ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2XNZ FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.59Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=3AW:6-METHYL-1,3,5-TRIAZINE-2,4-DIAMINE'>3AW</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=NCO:COBALT+HEXAMMINE(III)'>NCO</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2xnz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2xnz OCA], [https://pdbe.org/2xnz PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2xnz RCSB], [https://www.ebi.ac.uk/pdbsum/2xnz PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2xnz ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | The increasing number of RNA crystal structures enables a structure-based approach to the discovery of new RNA-binding ligands. To develop the poorly explored area of RNA-ligand docking, we have conducted a virtual screening exercise for a purine riboswitch to probe the strengths and weaknesses of RNA-ligand docking. Using a standard protein-ligand docking program with only minor modifications, four new ligands with binding affinities in the micromolar range were identified, including two compounds based on molecular scaffolds not resembling known ligands. RNA-ligand docking performed comparably to protein-ligand docking indicating that this approach is a promising option to explore the wealth of RNA structures for structure-based ligand design. | ||
| - | + | Novel Ligands for a Purine Riboswitch Discovered by RNA-Ligand Docking.,Daldrop P, Reyes FE, Robinson DA, Hammond CM, Lilley DM, Batey RT, Brenk R Chem Biol. 2011 Mar 25;18(3):324-35. PMID:21439477<ref>PMID:21439477</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| + | </div> | ||
| + | <div class="pdbe-citations 2xnz" style="background-color:#fffaf0;"></div> | ||
| - | + | ==See Also== | |
| + | *[[Riboswitch 3D structures|Riboswitch 3D structures]] | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Bacillus subtilis]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Batey RT]] | ||
| + | [[Category: Brenk R]] | ||
| + | [[Category: Daldrop P]] | ||
| + | [[Category: Hammond CM]] | ||
| + | [[Category: Lilley DMJ]] | ||
| + | [[Category: Reyes FE]] | ||
| + | [[Category: Robinson DA]] | ||
Current revision
xpt-pbuX C74U Riboswitch from B. subtilis bound to acetoguanamine identified by virtual screening
| |||||||||||
